Educational guide
Bevacizumab Reference Peptide for cancer targeting research
Bevacizumab Reference Peptide US$184.72 Excluding tax and shipping fees In stock Description About Bevacizumab Reference Peptide Bevacizumab Reference Peptide (Uniprot: A0A8C5VZ35) is an Ig-like domain-containing protein for cancer-targeting research. The Beva
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Bevacizumab Reference Peptide
US$184.72
Excluding tax and shipping fees
In stock
Description
About Bevacizumab Reference Peptide
Bevacizumab Reference Peptide (Uniprot: A0A8C5VZ35) is an Ig-like domain-containing protein for cancer-targeting research. The Bevacizumab Reference Peptide, H-STAYLQMNSLR-OH from JPT is produced under strict quality control and quality management.
Bevacizumab Reference Peptide - Specifications
Peptide sequence: H-STAYLQMNSLR-OH
Amount: 0.5 mg
Purity: > 90% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Application(s): Cancer research
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
Non-RGD Cancer Peptides from JPT
Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.
Benefits of JPT’s Non-RGD Cancer Peptides
Each peptide quality controlled and guaranteed for identity and purity
CoA and HPLC-MS data available
High batch-to-batch consistency
Synthesis protocols designed to avoid toxic contaminants and side products
Provision of freeze dried aliquots for enhanced stability
Proven track record for applications in clinical studies
References
References for Bevacizumab Reference Peptide
ReferencesRead References with Peptides made by JPT
Documentation
Documentation for Bevacizumab Reference Peptide
Bevacizumab Reference Peptide.pdf
Properties
Properties of Bevacizumab Reference Peptide
0.5 mg
Cancer biomarker research
Cancer peptides
Freeze-dried in plastic vial
Microcebus murinus
Bevacizumab
>90% (HPLC-MS)
No
Further Information to Bevacizumab Reference Peptide
Values
H-STAYLQMNSLR-OH
11mer cancer peptide